article thumbnail

Abstract TP270: Development and Validation of a Nomogram Model for Predicting Early Neurological Deterioration in Acute Ischemic Stroke Patients Treated With Intravenous Thrombolysis

Stroke Journal

Objective:A proportion of acute ischemic stroke (AIS) patients suffer from early neurological deterioration (END) within 24 hours following intravenous thrombolysis (IVT), which greatly increases the risk of poor prognosis of these patients.

article thumbnail

Abstract TP20: Intravenous thrombolysis versus early antiplatelet therapy in acute Ischemic Stroke with Small Artery Occlusion

Stroke Journal

Patients with elevated traditional risk factors at admission may benefit more from thrombolytic therapy compared to those with high inflammatory response indicators. Stroke, Volume 56, Issue Suppl_1 , Page ATP20-ATP20, February 1, 2025.

article thumbnail

Kidney disease linked to increased mortality after stroke thrombolysis

Medical Xpress - Cardiology

Renal dysfunction, especially chronic kidney disease, is the biggest risk factor of mortality among thrombolysed stroke patients, according to a retrospective cohort observational study published in Medicine.

article thumbnail

Treatment and Outcomes of Cervical Artery Dissection in Adults: A Scientific Statement From the American Heart Association

Stroke Journal

Cervical artery dissection occurs as a result of the interplay among risk factors, minor trauma, anatomic and congenital abnormalities, and genetic predisposition. The diagnosis can be challenging both clinically and radiologically.

article thumbnail

Differences in left ventricular myocardial function and infarct size in female patients with ST elevation myocardial infarction and spontaneous coronary artery dissection

Frontiers in Cardiovascular Medicine

Results The two groups were similar in age, risk factors, comorbidities, and complications. SCAD-STEMI patients more often had Thrombolysis in Myocardial Infarction 3 flow, while type 1 STEMI patients were more often treated with percutaneous coronary intervention and dual antiplatelet therapy.

article thumbnail

Study Finds Olezarsen Cuts Triglyceride Levels by About Half

DAIC

Brian Bergman, MD “Treatments to reduce high triglycerides are an unmet clinical need,” said Brian Bergmark, MD , of the Thrombolysis in Myocardial Infarction (TIMI) Study Group at Brigham and Women’s Hospital and Harvard Medical School and the study’s principal investigator. and Canada. Patients’ median triglyceride level was 242 mg/dL.

article thumbnail

Random Survival Forest Machine Learning for the Prediction of Cardiovascular Events Among Patients With a Measured Lipoprotein(a) Level: A Model Development Study

Circulation: Genomic and Precision Medicine

BACKGROUND:Established risk models may not be applicable to patients at higher cardiovascular risk with a measured Lp(a) (lipoprotein[a]) level, a causal risk factor for atherosclerotic cardiovascular disease.METHODS:This was a model development study. Circulation: Genomic and Precision Medicine, Ahead of Print.